Coldstream Capital Management Inc Akero Therapeutics, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AKRO
# of Institutions
249Shares Held
80.1MCall Options Held
228KPut Options Held
943K-
Rtw Investments, LP New York, NY7.42MShares$333 Million4.92% of portfolio
-
Janus Henderson Group PLC London, X07.07MShares$318 Million0.16% of portfolio
-
Wellington Management Group LLP Boston, MA5.94MShares$267 Million0.05% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$251 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$235 Million7.15% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.09B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...